Previous Close | 17.18 |
Open | 17.03 |
Bid | 17.68 x 300 |
Ask | 17.78 x 100 |
Day's Range | 16.06 - 17.74 |
52 Week Range | 9.40 - 17.75 |
Volume | |
Avg. Volume | 154,493 |
Market Cap | 716.914M |
Beta (5Y Monthly) | 0.63 |
PE Ratio (TTM) | 47.84 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.48 (2.71%) |
Ex-Dividend Date | Jun 05, 2024 |
1y Target Est | N/A |
TEANECK, N.J., May 08, 2024--Phibro Animal Health Corporation (Nasdaq: PAHC) ("Phibro" or the "Company") today announced financial results for its third quarter ended March 31, 2024, and its updated financial guidance for the year ending June 30, 2024.
PARSIPPANY, N.J. & TEANECK, N.J., April 28, 2024--Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024.
TEANECK, N.J., April 18, 2024--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 8, 2024, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 9, 2024, at 9:00 AM Eastern Time.